Axin and GSK3-β control Smad3 protein stability and modulate TGF-β signaling

被引:212
作者
Guo, Xing [1 ]
Ramirez, Alejandro [2 ]
Waddell, David S. [1 ]
Li, Zhizhong [1 ]
Liu, Xuedong [2 ]
Wang, Xiao-Fan [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
[2] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA
关键词
smad3; TGF-beta; axin; GSK3-beta; ubiquitination; protein stability;
D O I
10.1101/gad.1590908
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The broad range of biological responses elicited by transforming growth factor-beta (TGF-beta) in various types of tissues and cells is mainly determined by the expression level and activity of the effector proteins Smad2 and Smad3. It is not fully understood how the baseline properties of Smad3 are regulated, although this molecule is in complex with many other proteins at the steady state. Here we show that nonactivated Smad3, but not Smad2, undergoes proteasome-dependent degradation due to the concerted action of the scaffolding protein Axin and its associated kinase, glycogen synthase kinase 3-beta (GSK3-beta). Smad3 physically interacts with Axin and GSK3-beta only in the absence of TGF-beta. Reduction in the expression or activity of Axin/GSK3-beta leads to increased Smad3 stability and transcriptional activity without affecting TGF-beta receptors or Smad2, whereas overexpression of these proteins promotes Smad3 basal degradation and desensitizes cells to TGF-beta. Mechanistically, Axin facilitates GSK3-beta-mediated phosphorylation of Smad3 at Thr66, which triggers Smad3 ubiquitination and degradation. Thr66 mutants of Smad3 show altered protein stability and hence transcriptional activity. These results indicate that the steady-state stability of Smad3 is an important determinant of cellular sensitivity to TGF-beta, and suggest a new function of the Axin/GSK3-beta complex in modulating critical TGF-beta/Smad3-regulated processes during development and tumor progression.
引用
收藏
页码:106 / 120
页数:15
相关论文
共 67 条
[11]   Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway [J].
Furuhashi, M ;
Yagi, K ;
Yamamoto, H ;
Furukawa, Y ;
Shimada, S ;
Nakamura, Y ;
Kikuchi, A ;
Miyazono, K ;
Kato, M .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (15) :5132-5141
[12]   Integrin signalling during tumour progression [J].
Guo, WJ ;
Giancotti, FG .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (10) :816-826
[13]   P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST [J].
HANNON, GJ ;
BEACH, D .
NATURE, 1994, 371 (6494) :257-261
[14]  
Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147
[15]   TGF-beta signalling from cell membrane to nucleus through SMAD proteins [J].
Heldin, CH ;
Miyazono, K ;
tenDijke, P .
NATURE, 1997, 390 (6659) :465-471
[16]   SMAD destruction turns off signalling [J].
Heldin, CH ;
ten Dijke, P .
NATURE CELL BIOLOGY, 1999, 1 (08) :E195-E197
[17]   Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation [J].
Hoeflich, KP ;
Luo, J ;
Rubie, EA ;
Tsao, MS ;
Jin, O ;
Woodgett, JR .
NATURE, 2000, 406 (6791) :86-90
[18]   MODULATION OF THE GLYCOGEN-SYNTHASE KINASE-3 FAMILY BY TYROSINE PHOSPHORYLATION [J].
HUGHES, K ;
NIKOLAKAKI, E ;
PLYTE, SE ;
TOTTY, NF ;
WOODGETT, JR .
EMBO JOURNAL, 1993, 12 (02) :803-808
[19]   Transforming growth factor β stimulation of colorectal cancer cell lines:: Type II receptor bypass and changes in adhesion molecule expression [J].
Ilyas, M ;
Efstathiou, JA ;
Straub, J ;
Kim, HC ;
Bodmer, WF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3087-3091
[20]   Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity [J].
Inman, GJ ;
Nicolás, FJ ;
Hill, CS .
MOLECULAR CELL, 2002, 10 (02) :283-294